Pedro Villablanca Spinetto
Albert Einstein College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pedro Villablanca Spinetto.
Journal of the American College of Cardiology | 2015
Mohsin Salih; Yansoun Elmasry; Pedro Villablanca Spinetto; Hameem Kawsar; John C. Somberg
Antiplatelet agents are used for secondary prevention in patients with ischemic stroke or transient ischemic attack. Emerging studies suggest that early administration of dual antiplatelet therapy (DAPT) may be better than single antiplatelet therapy for the prevention of recurrent ischemic stroke,
Journal of the American College of Cardiology | 2017
Maday Gonzalez; Pedro Villablanca Spinetto; Arthur Omondi; Mohammed Makkiya; Peter Vlismas; Jose Wiley
Background: Percutaneous renal denervation (RDN) was heralded as a novel approach to treat resistant hypertension (RH), however evidence supporting its efficacy is conflicting. We therefore conducted an updated meta-analysis of randomized controlled trials (RCTs) evaluating the effect of RDN on
Journal of the American College of Cardiology | 2016
Evann Eisenberg; Peter Vlismas; Pedro Villablanca Spinetto; Daniel M. Spevack
Measurement of the left ventricular outflow tract (LVOT) diameter is a key parameter in the calculation of stroke volume, aortic valve area and mitral valve area on transthoracic echocardiography (TTE). We had observed that the numeric value for body surface area (BSA) reported in m2 frequently
Journal of the American College of Cardiology | 2015
Pedro Villablanca Spinetto; David F. Briceno; Andrea Mignatti; Rasha Al-Bawardy; Salvador Villablanca; David P. Slovut
Transcatheter aortic valve replacement (TAVR) is an alternative to surgical aortic-valve replacement (SAVR) for high-risk patients with severe aortic stenosis (AS). Our objective was to evaluate the efficacy and safety of TAVR compared with SAVR in high-risk patients with AS. We conducted
Journal of the American College of Cardiology | 2015
Pedro Villablanca Spinetto; David F. Briceno; Amell Fredrik; Felipe N. Albuquerque; Salvador Villablanca; Mark A. Menegus; Vankeepuram S. Srinivas; Mark A. Greenberg; Anna E. Bortnick; Ernest Monrad; Michael Johnson; Robert Pyo
The benefits of 1-year of dual antiplatelet therapy (DAPT) as compared with short-term (≤ 6 months), in patients undergoing percutaneous coronary intervention (PCI) after drug-eluting stents (DES) remains controversial. We performed a meta-analysis of 1-year versus short-term duration DAPT in
Journal of the American College of Cardiology | 2015
Pedro Villablanca Spinetto; David F. Briceno; Jerson Munoz-Mendoza; Jose Iturrizaga; Marissa Lombardo; Evann Eisenberg; Nicole Cyrille; German Giese; Mario J. Garcia
Studies have suggested that therapeutic hypothermia (TH) in acute ST elevation myocardial infarction (STEMI) might be beneficial. The supportive evidence showing beneficial outcomes is limited. We performed a meta-analysis of randomized controlled trials (RCT) to assess the efficacy and safety of TH
Journal of the American College of Cardiology | 2015
Pedro Villablanca Spinetto; David F. Briceno; Joseph Donnelly; Cesar Y. Guerrero-Miranda; Salvador Villablanca; Vankeepuram S. Srinivas; Mark A. Menegus; Anna E. Bortnick; Michael Johnson; Ernest Monrad; Mark A. Greenberg; David P. Slovut; Robert Pyo
Studies employing primary percutaneous intervention (PCI) in patients with ST segment elevation myocardial infarction (STEMI) have shown discordant results regarding the relative benefits of treating the culprit lesion only vs all significant stenosis. We performed a meta-analysis comparing PCI of
Journal of the American College of Cardiology | 2015
David F. Briceno; Pedro Villablanca Spinetto; Nicole Cyrille; Daniele Massera; Eric Bader; Eric Manheimer; Philip Aagaard; Kevin J. Ferrick; Jay N. Gross; Soo G. Kim; Andrew Krumerman; Eugen C. Palma; Nils Guttenplan; John D. Fisher; Mario J. Garcia; Andrea Natale; Luigi Di Biase
Different strategies have been evaluated for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). We sought to evaluate the efficacy and safety of different approaches compared to standard therapy with warfarin. We conducted electronic database searches of phase III
Journal of Cardiovascular Diseases and Diagnosis | 2015
David F. Briceno; Anand Jagannath; Martin N. Cohen; Robert Pyo; Pedro Villablanca Spinetto
Coronary vasospasm is uncommon in pregnancy and the post-partum period. We present a very rare case about an acute coronary vasospasm in a 36-year-old woman, 2 weeks postpartum. The coronary arteriograms showed a coronary vasospasm in the distal left anterior descending and circumflex coronary arteries. EKG presentation was atypical, with T-wave inversions in leads I, aVl, V2-V6. To our knowledge, this is the first case with a welldocumented coronary artery vasospasm in a postpartum woman, without the classic ST elevation on EKG. Management should follow the usual principles of care for acute coronary vasospasm.
publisher | None
author